Completed Research FAQ
QUESTION: Do I have to be a member of HOPA to submit an abstract?
ANSWER: No, you do not need to be a member of HOPA in order to submit an abstract.
QUESTION: Do you accept industry-supported abstracts?
ANSWER: Yes, we do review and consider for acceptance industry-supported abstracts. Industry-supported research is defined by HOPA as research that is funded by a pharmaceutical company whose primary purpose is to assess safety and/or efficacy of an intervention in a clinical setting. Additionally, industry-supported research refers to material regarding the research, development, market, and/or distribution of medications that is owned/patented/promoted and must be approved by the pharmaceutical company supporting that research. An industry employee however, may not present research at the annual HOPA meeting unless they were a principal or co-principal investigator on the project. All financial interests and commercial or federal funded research must be disclosed upon submission. For more clarification on these terms, please view the Authorship section on the Call for Abstracts home page.
QUESTION: May I present my research as an encore submission?
ANSWER: Yes, we do consider accepting encore submissions. Consideration will be given to the platform where the research has been presented previously.
QUESTION: What is an encore submission?
ANSWER: An encore submission is one that has been previously presented elsewhere, prior to it being presented at the HOPA annual meeting.
QUESTION: Do I have to be present at the annual meeting in order to submit an abstract?
ANSWER: Authors must be available to present during poster exhibition sessions and to discuss questions from participants. The presenter of the poster must register for at least the day of the annual meeting on which they are scheduled to present. Only those presenters committed to attending the conference may submit an abstract.
QUESTION: I have submitted an abstract, but have found out I am no longer able to attend the meeting. May I have someone present my poster for me?
ANSWER: A poster may only be presented by one of the authors of the poster except in the case of industry-sponsored research. In the case of industry-sponsored research, an industry employee may not present research at the annual HOPA meeting unless they were a principal or co-principal investigator on the project
QUESTION: Are any expenses paid for if I submit an abstract?
ANSWER: Presenters are responsible for all expenses such as production and shipping of posters, and for personal expenses such as travel, hotel, and meeting registration fees.
QUESTION: Should I submit my research into a particular category?
ANSWER: Yes, your research should be submitted into either the clinical/translational research or practice management category.
QUESTION: What types of research should not be submitted?
ANSWER: We accept a variety of types of research including case reports, case series and meta-analyses. Abstracts must be the presenter’s original research.
QUESTION: Do you have any examples of quality research that has previously been submitted?
ANSWER: Please view the Completed Research PDF examples of previously submitted abstracts, both in the practice management field and in the clinical/translational research field. These examples include abstracts that have been accept as platform presentations in years past.
QUESTION: How long may my abstract be?
ANSWER: Your abstract should be no longer than 400 words and should be single-spaced.
QUESTION: What happens to my abstract once it has been submitted?
ANSWER: A group of reviewers, all members of the HOPA Research Abstract Review Work Group will score and discuss your abstract. The scoring will determine if you have submitted one of the best abstracts and would be asked to present your abstract as a platform presentation at the annual meeting. Reviews of all completed research abstracts will be based on the following criteria:
- Background/Rationale includes purpose, significance and context;
- Objective(s) are measureable and clearly defined;
- Methodology is appropriate, organized and replicable;
- Results are related to objective & method and are described appropriately;
- Conclusion/Discussion offers a meaningful interpretation of results and future directions of the project;
- Abstracts are also reviewed for its implications for hematology/oncology pharmacy practice, uniqueness and innovation in pharmacy practice as well as overall study quality
QUESTION: May I revise my abstract once it has been submitted?
ANSWER: Abstracts may be revised at any time up until the submission deadline. A confirmation email will be sent upon submission, giving the submitter the password-protected URL for the abstract.
QUESTION: Who is eligible for the platform presentations?
ANSWER: Abstracts submitted by HOPA members who are the principal or co-principal investigator of the research will be considered for a platform presentation. Encore presentations are not eligible for a platform presentation of the work. The principal or co-principal investigator must be the one to present the work at the annual meeting if accepted for a platform presentation.
QUESTION: May I have a QR code on my poster?
ANSWER: A QR code will be considered on a case-by-case basis. The QR code should only link to the poster online and not to any other site.
QUESTION: Will my abstract be published anywhere?
ANSWER: Selected completed research abstracts will be published in a supplement of an issue of the Journal of Oncology Pharmacy Practice.